PARAMETRIC PORTFOLIO ASSOCIATES LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,889,000
+5.9%
256,291
-7.6%
0.00%0.0%
Q4 2021$1,784,000
+4.6%
277,519
-5.3%
0.00%0.0%
Q3 2021$1,706,000
-4.2%
293,130
+70.0%
0.00%0.0%
Q2 2021$1,780,000
+92.0%
172,474
+95.7%
0.00%0.0%
Q1 2021$927,000
-24.2%
88,111
+11.6%
0.00%0.0%
Q4 2020$1,223,000
+83.9%
78,979
+73.4%
0.00%
Q3 2020$665,000
-75.7%
45,538
-68.5%
0.00%
-100.0%
Q2 2020$2,739,000
-9.9%
144,600
-8.7%
0.00%
-33.3%
Q1 2020$3,041,000
+56.4%
158,310
+56.1%
0.00%
+200.0%
Q4 2019$1,944,000
+700.0%
101,395
+301.4%
0.00%
Q3 2019$243,000
+89.8%
25,261
+18.0%
0.00%
Q2 2019$128,000
-27.7%
21,405
+9.3%
0.00%
Q2 2017$177,000
-50.7%
19,583
-30.0%
0.00%
-100.0%
Q1 2017$359,000
+88.9%
27,988
+38.6%
0.00%
Q4 2016$190,000
-2.1%
20,199
+1.4%
0.00%
Q3 2016$194,000
-36.8%
19,925
+76.4%
0.00%
-100.0%
Q2 2015$307,000
-26.7%
11,298
+0.8%
0.00%0.0%
Q4 2014$419,00011,2050.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders